Monoclonality and Abnormal Parathyroid Hormone Genes in Parathyroid Adenomas, New England Journal of Medicine, vol.318, issue.11, pp.658-662, 1988. ,
DOI : 10.1056/NEJM198803173181102
Hyperparathyroïdie primaire, Forum Med Suisse, vol.9, issue.44, pp.791-798, 2009. ,
Suppression by Calcium of Serum Levels of Intact Parathyroid Hormone in Patients with Primary Hyperparathyroidism, Hormone Research, vol.39, issue.3-4, pp.3-4146, 1993. ,
DOI : 10.1159/000182715
Primary hyperparathyroidism: diagnosis, evaluation, and treatment, Current Opinion in Internal Medicine, vol.4, issue.1, pp.345-352, 2004. ,
DOI : 10.1097/01.med.0000144035.12532.a7
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis, New England Journal of Medicine, vol.350, issue.15, pp.1516-1525, 2004. ,
DOI : 10.1056/NEJMoa031633
of Suppressibility of Parathyroid Function by Calcium in Primary Hyperparathyroidism*, The Journal of Clinical Endocrinology & Metabolism, vol.48, issue.4, pp.604-610, 1979. ,
DOI : 10.1210/jcem-48-4-604
Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism, J Clin Endocrinol Metab, vol.85, issue.12, pp.4789-4794, 2000. ,
hyperparathyroïdie secondaire lors de l'insuffisance rénale chronique. Réalités en rhumatologie, pp.12-13, 2012. ,
Functional evidence for two types of parathyroid adenoma, Clinical Endocrinology, vol.1, issue.5, pp.593-601, 1998. ,
DOI : 10.1007/s002689900154
Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3., Proceedings of the National Academy of Sciences, vol.89, issue.17, pp.8097-8101, 1992. ,
DOI : 10.1073/pnas.89.17.8097
Cinacalcet: An oral calcimimetic agent for the managementof hyperparathyroidism, Clinical Therapeutics, vol.27, issue.11, pp.1725-1751, 2005. ,
DOI : 10.1016/j.clinthera.2005.11.015
Hyperparathyro??die??: applications du scanner et de l???IRM, Journal de Radiologie, vol.90, issue.3, 2009. ,
DOI : 10.1016/S0221-0363(09)72529-6
Biologie de l???hyperparathyro??die primaire??: pr??l??vements veineux ??tag??s, Journal de Radiologie, vol.90, issue.3, pp.413-419, 2009. ,
DOI : 10.1016/S0221-0363(09)72531-4
Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism, Kidney International, vol.51, issue.1, pp.328-336, 1997. ,
DOI : 10.1038/ki.1997.41
Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200 mg once daily, American Journal of Kidney Diseases, vol.44, issue.6, pp.1070-1076, 2004. ,
DOI : 10.1053/j.ajkd.2004.08.029
Hyperparathyroïdie primitive, Néphrologie, vol.21, issue.6, pp.283-290, 2000. ,
Hypercalcemia with low-normal serum intact PTH: A novel presentation of primary hyperparathyroidism, The American Journal of Medicine, vol.91, issue.5, pp.547-548, 1991. ,
DOI : 10.1016/0002-9343(91)90193-2
Hyperparathyroïdie primitive. Encl Méd Chir, Endocrinologie-Nutrition, pp.10-012, 2002. ,
Génétique des néoplasies endocriniennes multiples : implications cliniques, Revue Medicale Suisse, vol.1, issue.6, pp.408-413, 2005. ,
Metabolism and disposition of calcimimetic agent cinacalcet HCL in human and animal models. Drug Metab Dispos, pp.1491-1500, 2004. ,
Cinacalcet Reduces Serum Calcium Concentrations in Patients with Intractable Primary Hyperparathyroidism, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.8, pp.2766-2772, 2009. ,
DOI : 10.1210/jc.2008-2640
Global vitamin D status and determinants of hypovitaminosis D, Osteoporosis International, vol.60, issue.90, pp.1807-1820, 2009. ,
DOI : 10.1007/s00198-009-0954-6
The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis, British Journal of Clinical Pharmacology, vol.125, issue.6, pp.726-734, 2004. ,
DOI : 10.1046/j.1523-1755.1998.00735.x
No Effect of Renal Function or Dialysis on Pharmacokinetics of Cinacalcet (Sensipar??/Mimpara??), Clinical Pharmacokinetics, vol.44, issue.6, pp.509-516, 2005. ,
DOI : 10.2165/00003088-200544050-00004
Cinacalcet Treatment of Primary Hyperparathyroidism: Biochemical and Bone Densitometric Outcomes in a Five-Year Study, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.12, pp.4860-4867, 2009. ,
DOI : 10.1210/jc.2009-1472
Cinacalcet HCl Reduces Hypercalcemia in Primary Hyperparathyroidism across a Wide Spectrum of Disease Severity, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.1, pp.9-18, 1993. ,
DOI : 10.1210/jc.2010-1221
Hyperparathyro??die primaire??: ??chographie et scintigraphie, Journal de Radiologie, vol.90, issue.3, pp.49-60, 2009. ,
DOI : 10.1016/S0221-0363(09)72527-2
The Natural History of Primary Hyperparathyroidism with or without Parathyroid Surgery after 15 Years, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.9, pp.3462-3470, 2008. ,
DOI : 10.1210/jc.2007-1215
???Incipient??? Primary Hyperparathyroidism: A ???Forme Fruste??? of an Old Disease, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.11, pp.5348-5352, 2003. ,
DOI : 10.1210/jc.2003-031014
The diagnosis and management of asymptomatic primary hyperparathyroidism, Nature Clinical Practice Endocrinology & Metabolism, vol.53, issue.9, pp.494-503, 2006. ,
DOI : 10.1038/ncpendmet0265
Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.2, pp.351-365, 2009. ,
DOI : 10.1210/jc.2008-1760
A 10-Year Prospective Study of Primary Hyperparathyroidism with or without Parathyroid Surgery, New England Journal of Medicine, vol.341, issue.17, pp.1249-1255, 1999. ,
DOI : 10.1056/NEJM199910213411701
Cinacalcet Hydrochloride Reduces the Serum Calcium Concentration in Inoperable Parathyroid Carcinoma, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.10, pp.3803-3808, 2007. ,
DOI : 10.1210/jc.2007-0585
A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy, Nature Clinical Practice Endocrinology & Metabolism, vol.90, issue.5, pp.291-296, 2006. ,
DOI : 10.1038/ncpendmet0189
Evaluation of a standardized short-time calcium suppression test in healthy subjects: interest for the diagnosis of primary hyperparathyroidism, European Journal of Endocrinology, vol.157, issue.3, pp.351-357, 2007. ,
DOI : 10.1530/EJE-07-0132
Hyperparathyro??die primaire, Journal de Radiologie, vol.90, issue.3, pp.392-396, 2009. ,
DOI : 10.1016/S0221-0363(09)72526-0
Incidence of Primary Hyperparathyroidism in Rochester, Minnesota, 1993-2001: An Update on the Changing Epidemiology of the Disease, Journal of Bone and Mineral Research, vol.17, issue.2, pp.171-177, 1993. ,
DOI : 10.1359/JBMR.050910
Large carboxy-terminal parathyroid hormone (PTH) fragment with a relatively longer half-life than 1-84 PTH is secreted directly from the parathyroid gland in humans, European Journal of Endocrinology, vol.149, issue.4, pp.301-306, 2003. ,
DOI : 10.1530/eje.0.1490301